Introduction
Stress to the endoplasmic reticulum (ER) is recognized as cellular insult to a protein-folding factory, responsible for the biosynthesis, folding, assembly and modification of numerous soluble proteins and membrane proteins [1] . Disturbance to normal functions of the ER leads to an evolutionarily conserved stress response, the unfolded protein response, which is primarily aimed at damage compensating but may eventually trigger cell death if the dysfunction is severe or prolonged [2, 3] .Although the ER stress has been reported to be linked to various diseases such as diabetes [4, 5] , neurodegenerative diseases [6] , and osteogenesis imperfecta [7] , the role of the ER stress in the pathogenesis of osteoporosis still remains unclear.
Osteoporosis is characterized by reduced bone mass, alterations in the microarchitecture of bone tissue, reduced bone strength, and an increased risk of fracture [8, 9] . Bone remodeling is a continuous bone resorbing and rebuilding process, undertaken mainly by bone-resorbing osteoclasts and bone-forming osteoblasts [10] . Diminished bone formation and/or excessive bone resorptionduring bone remodeling results in osteoporosis. Some murine models for bone diseases exhibit useful insights into possible linkage of osteoporotic pathogenesis to the ER stress in osteoblasts [11] . For instance, increased apoptotic death of osteoblasts is observed in postmenopausal osteoporosis as well as glucocorticoid-induced osteoporosis [12] . However, possible involvement of the ER stress in the development of osteoporosis has not well been understood.
The major types of osteoporosis in humans include postmenopausal osteoporosis, disuse osteoporosis, and glucocorticoid-induced osteoporosis [13] [14] [15] [16] . Unloading in animals is often mimicked by tail suspension or sciatic neurectomy for quantitative evaluation of the progress of disuse osteoporosis [13, 17, 18] . But the mechanism underlying enhanced osteoclasts activity and impaired osteoblasts functions remains to be clarified. In the current study, the unloading model was used to analyze the pathogenesis of osteoporosis, and the relationship between ER stress and osteoporosis.
Salubrinal is a synthetic chemical (480 Da, C21H17Cl3N4OS) known to block 5 the dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α), which plays a critical role in the responses to the ER stress [19] . The elevated phosphorylation level of eIF2α activates translation of activating transcription factor 4 (ATF4), which is one of the key transcription factors in bone formation [20] . Little is known, however, on its therapeutic effects on unloading-induced osteoporosis. In the present study, the unloading model was used to analyze the pathogenesis of osteoporosis, and salubrinal was employed as an agent to evaluate the role of ER stress in disuse osteoporosis.
Using unloaded mice as a model for disuse osteoporosis, we first investigated herein the pathogenesis of osteoporosis, focusing on the role of ER stress in the development of osteoporosis. We also examined the effects of salubrinal to unloaded mice, target the development of bone marrow-derived cells that give rise to both bone-forming osteoblasts and bone-resorbing osteoclasts.
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Materials and Methods
Animals and materials preparation
One hundred and seventeen C57BL/6 female mice (Animal Center of Academy of Military Medical Sciences, China), ~16 weeks of age, were used. Four to five mice per cage were housed under pathogen-free conditions, and were fed with standard laboratory rodent chow and water ad libitum. Mice were maintained at a constant temperature of 25 , and kept on a 12-hour light/dark cycle during the experimental procedure. All experiments were carried out according to the National Institutes of Health Guide for Care and Use of Laboratory Animals and were approved by the Ethics Committee of Tianjin Medical University. Murine receptor activator of nuclear factor kappa-B ligand (RANKL) and murine macrophage-colony stimulating factor (M-CSF) were purchased from PeproTech (Rocky Hills, NC, USA). Dulbecco's Modified Eagle's Medium (DMEM), Minimum Essential Medium Alpha (MEM-α), fetal bovine serum, penicillin, streptomycin and trypsin were purchased from Invitrogen (Carlsbad, CA, USA). Other chemicals were purchased from Sigma (St.
Louis, MO, USA) unless otherwise stated.
Experimental design
In the first set of experiments, fifty-four mice were used to evaluate the role of ER stress in the development of unloading-induced osteoporosis. These mice were divided into nine groups: the age-matched control (AC; n = 6) and eight hindlimb unloading groups (HU). To examine the pathogenesis of disuse osteoporosis, unloaded mice were subdivided based on the duration for unloading such as 3h, 6h, 12h, 1d, 2d, 3d, 7d, and 14d (n = 6 for each subgroup).
In the second set of experiments, forty-five mice were employed to assess the effect of salubrinal on unloading-induced osteoporosis. These mice were divided into three groups (n = 21): the age-matched control group (AC), hindlimb unloading group (HU), and salubrinal-treated hindlimb unloading group (US). Thirty mice (HU and US) were subjected to hindlimb unloading for 2 weeks. All animals were weighed prior to any treatment and at sacrifice on 2 weeks.
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In vivo tail suspension
The mice were outfitted with a custom-made tail harnesses and suspended from an overhead pulley system in the customized cage. The position of the mice was adjusted to maintain in a ~30° head-down tilt with the hindlimbs elevated above the floor. The mice were able to ambulate within the cage using their forelimbs, which remained in contact with the cage floor. However, their hindlimbs remained suspended in air and consequently were unable to receive ground reaction forces (Fig.   1A ). Food and water were provided on the cage floor. For the age-matched control group, mice were housed individually under the same conditions but were not subjected to hindlimb unloading [21] [22] [23] .
Subcutaneous administration of salubrinal
In the 2 nd set of experiments, for salubrinal-treated group, unloaded mice received subcutaneous injections of salubrinal (Tocris Bioscience, Ellisville, MO, USA) in propylene glycol daily at a dose of 1 mg/kg body weight for 2 weeks. The placebo mice received an equal volume of vehicle [12] .
Measurements of bone mineral density and bone mineral content
The animals were anesthetized by 1.5% isoflurane at a flow rate of 1.0 L/min, placed on the platform in the prone position, and their images were acquired in ~5 min. Using peripheral dual energy X-ray absorptiometry (pDEXA; PIXImus II, Lunar Corp, Madison, WI, USA), bone mineral density (BMD, g/cm 2 ) and bone mineral content (BMC, g) of the bilateral femur were measured before unloading and sacrifice (version 1.47). We scanned the entire animal, and conducted ROI analysis. The changes in BMD and BMC were determined, and statistical analysis was conducted.
Micro-computed tomography
Micro-computed tomography (µCT) was performed using a ScancovivaCT 40 (Scanco Medical AG, Bassersdorf, Switzerland), a high-resolution desk-top system as previously reported [24] . Briefly, the excised left distal femora were scanned using an 8 X-ray source set at 60 kV with 6-μm pixel size. The trabecular bone compartment was segmented from the cortical shell for 50 slices in a region ~ 0.5 mm proximal to the most distal portion of the growth plate. A three-dimensional (3D) analysis was done to determine bone volume fraction (BV/TV, %), trabecular number (Tb.N, 1/mm), trabecular thickness (Tb.Th, μm), and trabecular bone spacing (Tb.Sp, μm).
Histology, TRAP, MacNeal, TUNEL, and immunohistochemistry assays
The distal femora were fixed in 10% neutral buffered formalin for two days and decalcified in 14% EDTA for 2 weeks. Decalcified samples were embedded in paraffin, and 5-μm-thick coronal sections were cut. The slides were then processed for hematoxylin and Eosin (H&E) staining. The images of the distal femora were captured with an Olympus BX53 microscope and Olympus DP73 camera.
Measurements were performed within 1.6-mm 2 sample area on the proximal side of the growth plate (~0.8 mm proximal distance from the growth plate), in which B.Ar/T.Ar (bone area/total area) was determined.
Tartrate resistant acid phosphatase (TRAP) staining was used to determine osteoclast development [25] . The ratio between length of TRAP-positive cells and total circumference of bone trabecula were calculated. MacNeal's staining was used for identifying osteoblasts as described previously [26, 27] . The osteoblast number was normalized using the trabecular bone surface.
For immunohistochemical analysis, femoral sections were incubated with primary antibodies against nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) (Abcam, Cambridge, MA, USA) at 4 overnight. An immunohistochemical kit and 3, 3'-diaminobenzidine (DAB) (ZSGB-BIO, Beijing, China) substrate kit were used according to the manufacturer protocol. Histomorphometric measurements were conducted on the area of the proximal femur. Quantitative analysis was conducted in a blinded fashion [28] .
TUNEL assay
TUNEL staining was performed using a DeadEnd™ Fluorometric TUNEL 9 System (Promega, Madison, WI, USA) and apoptotic cells from the femoral section and MC3T3-E1 cells were detected [29, 30] . Fluorescently labelled cells were identified in 5 fields of view, and the relative percentage of TUNEL positive nuclei was determined using image analysis software (Cellsense standard software).
Isolation of bone marrow-derived cells for osteoclast development
After euthanasia, bone marrow-derived cells were collected by flushing the iliac with Iscove's MEM (Gibco-Invitrogen, Carlsbad, CA, USA) that contained 2% fetal bovine serum (FBS). Cells were separated by low-density gradient centrifugation and cultured in α-MEM supplemented with 10% FBS, 30 ng/ml murine macrophage-colony stimulating factor (M-CSF), and 20 ng/ml murine receptor activator of nuclear factor kappa-B ligand (RANKL). On day 3, the culture medium was replaced by α-MEM supplemented with 10% FBS, 30 ng/ml M-CSF, and 60 ng/ml RANKL. Cells were grown for three additional days [31, 32] .
Assays for colony-forming unit-fibroblasts (CFU-F) and colony-forming unit-osteoblasts (CFU-Ob)
To evaluate colony formation capability of fibroblast-like mesenchymal stem cells, the CFU-F assay was performed. In brief, bone marrow-derived cells (2 × 10 6 cells/ml) were cultured in 6-well culture plates in a complete MesenCult medium.
Fresh medium was exchanged every other day. On day 14, cells were stained using a HEMA-3 quick staining kit (Fisher Scientific, Waltham, MA, USA). The number of CFU-F colonies with more than 50 cells was counted, and the clusters of cells that did not present fibroblast-like morphology were excluded [24, 33, 34] .
In the CFU-Ob assay, bone marrow-derived cells were plated at 2 × 10 6 cells/ml in 6-well plates consisting of the osteogenic differentiation medium (MesenCult proliferation kit, supplemented with 10 nM dexamethasone, 50 μg/ml ascorbic acid 2-phosphate, and 10 mM β-glycerophosphate) [31] . The medium was changed every other day, and cells were cultured for 2 weeks. On day 14, cells were stained using an alkaline phosphatase (ALP) kit (Sigma-Aldrich, St. Louis, MO, USA). The 10 percentage of ALP-positive colonies was calculated.
Assays for Colony-forming unit-macrophage/monocyte (CFU-M) and Colony-forming unit-granulocyte-macrophages (CFU-GM)
The CFU-M and CFU-GM assays were conducted using bone marrow mononuclear cells as described previously [31, 35] . Approximately 2.5 × 10 4 bone marrow-derived cells from the iliac were prepared. Cells were seeded onto a 35-mm gridded dish, which was composed of methylcellulose supplemented with 30 ng/ml M-CSF and 20 ng/ml RANKL. Cells were cultured for 7 days in the presence and absence of salubrinal. The colony numbers of CFU-M and CFU-GM were converted to the numbers per iliac.
Assay for differentiation to mature osteoclasts
The osteoclast differentiation assay was performed using bone marrow-derived cells from unloading group in 96-well plates in the presence and absence of salubrinal [36] . During 6-day experiments, the culture medium was exchanged once on day 4. Adherent cells were fixed and stained with a tartrate resistant acid phosphate (TRAP)-staining kit (Sigma-Aldrich, St. Louis, MO, USA). TRAP-positive multinucleated cells (>3 nuclei) were identified as mature osteoclasts, and the area covered by mature osteoclasts was determined.
Assays for the migration and adhesion of pre-osteoclasts
Migration of osteoclasts was evaluated using a transwell assay as described previously with minor modifications [31] . Bone marrow-derived cells (2 × 10 chamber (attached onto the bottom of the transwells) was counted.
For assaying adhesion, osteoclast precursor cells (1 × 10 5 cells/well) were placed into 96-well plates coated with 5 μg/ml vitronectin in α-MEM supplemented with 30 ng/ml M-CSF [37] . After 30 min of incubation, cells were washed with PBS three times and fixed with 4% paraformaldehyde at room temperature for 10-15 min. Cells were stained with crystal violet, and the number of adherent cellswas counted.
Cell viability assay
An MTT assay was used to evaluate cell viability as previously described [38] . 
Western blot analysis
For Western blot analysis, protein samples were isolated from the femora using a mortar and pestle. Tissues were lysed in a radioimmunoprecipitation assay (RIPA) lysis buffer, containing protease inhibitors and phosphatase inhibitors (Roche Diagnostics GmbH, Mannheim, Germany). Isolated proteins were fractionated using 10% sodium dodecyl sulfate-polyacrylamide gels and electro-transferred to polyvinylidenedifluoride membranes (Millipore, Billerica, MA, USA) [28] . Primary 
Statistical analysis 12
The data were expressed as mean ± standard deviation (SD). Data were analyzed with independent-sample t test (for two groups) or one-way ANOVA (for more than two groups). For pair-wise comparisons, a post-hoc test was conducted using Fisher's protected least significant difference. Correlation analysis was performed using Pearson correlation coefficient test. The relative parameters (% change) such as body weight, BMD, and BMC were calculated as ([S-B]/B × 100 in %, where S = "sacrifice" and B = "baseline". All comparisons were two-tailed and statistical significance was assumed at p<0.05. The asterisks (*, **, and ***) represent p<0.05, p<0.01, and p<0.001, respectively.
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Results
The animals, used for tail suspension and administration of salubrinal, tolerated the procedures. No bruising or tissue damage was detected at the tail suspension site.
Unloading-driven alteration in body weight and B.Ar/T.Ar in the femur
During the 2-week experiment, age-matched control in body weight increased.
However, unloaded mice demonstrated a time-dependent decrease in body weight (Fig. 1B) . Compared to age-matched control, a statistically significant decrease was observed in these 4 unloaded groups (all p<0.001). Similar to the change of body weight, the histological samples of the distal femora from the unloaded mice showed a time-dependent decrease in B.Ar/T.Ar (Fig. 1C) . Compared to age-matched control, a statistically significant decrease was observed in HU3d (p<0.05), HU7d (p<0.001), and HU14d (p<0.001), no significant difference was found in HU1d (p=0.433).
Unloading-driven alteration in both osteoblast number and osteoclast number in the femur
Compared to the age-matched control mice, unloaded group showed that the number of osteoblasts on bone surface was significantly decreased in a time-dependent fashion in HU1d (p<0.05), HU3d (p<0.01), HU7d (p<0.01), and HU14d (p<0.001) (Fig. 1D) . However, unloaded group presented that the ratio of TRAP-positive cells to trabecular bone surface was significantly increased in a time-dependent manner in HU3d (p<0.01), HU7d (p<0.01), and HU14d (p<0.001), whereas HU1d showed no significant increase (p=0.335) ( Fig. 2A) .
Unloading stimulated development of osteoclasts and CFU-M/CFU-GM
Compared to the bone marrow-derived cells isolated from the age-matched control, the cells from the unloaded mice exhibited an increase in the surface area occupied by multi-nucleated osteoclasts (p<0.001) (Fig. 2B) . Pre-osteoclast cells isolated from the unloaded mice were more migratory than those from the age-matched control (p<0.001) (Fig. 2C ). In the adhesion assay, the cells isolated 14 from the unloaded mice presented an increase in adhesion over those from the age-matched control (p<0.001) (Fig. 2D) . Furthermore, the number of CFU-M (p<0.001; Fig. 2E ) and CFU-GM (p<0.001; Fig. 2F ) in an iliac significantly increased in the unloaded group.
Unloading-induced ER stress
Compared to the age-matched control, the unloading group significantly increased the expression of Bip in HU3h (p<0.01), HU6h (p<0.05) and HU12h (p<0.01), but decreased in HU2d, HU3d, HU7d (all p<0.05), and HU14d (p<0.01).
Meanwhile, compared to the age-matched control, unloading significantly increased the expression of p-eIF2α in HU3h and HU6h (both p<0.05), and HU12h group exhibited the same level as the age-matched control group (p=0.126), but decreased in a time-dependent manner in HU1d, HU3d, HU7d, and HU14d (all p<0.05). The unloading group increased the level of ATF4 in HU3h and HU6h (both p<0.05).
HU12h (p=0.176) and HU1d (p=0.053) exhibited no significant change to the age-matched control group, while they decreased in HU2d, HU3d, HU7d (all p<0.05), and HU14d (p<0.01) in a time-dependent manner. The expression of CHOP showed a significant increase after HU12h (all p<0.01) (Fig. 3A-E) . (Fig. 3F) .
Attenuation of unloading-induced effects in salubrinal-treated mice
Compared to age-matched control, unloading mice demonstrated a decrease in body weight (p<0.001), while subcutaneous administration of salubrinal for 2 weeks significantly suppressed the unloading-induced decrease in body weight (p<0.001; Fig.   4A ).
Compared to the age-matched control, the unloaded mice presented a significant reduction in BMD and BMC (both p<0.001). However, the unloaded mice treated with salubrinal exhibited a statistically significant recovery of BMD and BMC in the femur (both p<0.05) (Fig. 4 B&C) .
Micro-CT scanning at the distal femora (Fig. 4 D) indicated that the femoral BV/TV was increased from 18.7 ± 1.9 % (HU) to 24.1 ± 1.7 % (US) (p<0.05; Fig. 4E ).
The trabecular number increased from 5.16 ± 0.4 1/mm (HU) to 6.19 ± 0.42 1/mm (US) (p<0.05) (Fig. 4F) , and the trabecular thickness of the femur was increased with salubrinal in the present study (p<0.01; Fig. 4G ). However, the trabecular spacing of the femur was decreased by salubrinal treatment (p<0.05; Fig. 4H ).
Compared to age-matched control mice, unloaded mice presented a reduction in B.Ar/T.Ar (p<0.001). However, administration of salubrinal significantly restored B.Ar/T.Ar (p<0.001) (Fig. 4I) .
Salubrinal-driven enhancement of bone-forming osteoblasts in vivo
Compared to the age-matched control group, unloaded mice for 2 weeks presented a significant reduction in the number of osteoblast on trabecular bone surface by MacNeal's staining (p<0.001). However, two-week administration of salubrinal significantly increased the osteoblast number (p<0.001; Fig. 5A ).
Salubrinal-driven inhibition of apoptosis in bone cavity
TUNEL-positive cells at the distal femora presented a significant increase in unloaded mice compared to age-matched control mice (p<0.001), whereas the salubrinal-treated unloading mice was significant decreased them compared to unloaded mice (p<0.001; Fig. 5B ).
Salubrinal-driven differentiation of osteoblasts and development of fibroblasts
Without salubrinal, the percentage of ALP positive colonies was 30.5 ± 1.7% in AC and 25.6 ± 2.2% in HU (p<0.05) (Fig. 5C) . Administration of salubrinal at 1 mg/kg increased the osteoblast differentiation to 41.3 ± 1.6% in vivo (p<0.001). After administration of salubrinal at 0.5 μM in vitro, the percentage of ALP-positive colonies increased 5.1% (p<0.05; Fig. 5D ).
Compared to age-matched control, unloading mice presented a significant decrease in CFU-F (p<0.01). Salubrinal treated unloading mice produced more CFU-F colonies when compared to the cultures established from hindlimb unloaded mice (p<0.01; Fig. 5E ). Furthermore, administration of salubrinal at 0.5 μM in vitro increased CFU-F colonies when compared to the cultures established from unloaded mice (p<0.01; Fig. 5F ).
Salubrinal-driven inhibition of bone resorption and osteoclast development in vivo and in vitro
Compared to the age-matched control, TRAP staining of the distal femora showed that Oc.S/BS f was significantly increased in the unloaded mice (p<0.001).
However, the elevated ratio in the hindlimb unloaded group was significantly suppressed by salubrinal (p<0.001; Fig. 6A ).
Osteoclast formation was conducted using bone marrow-derived cells, the cells from the unloaded mice exhibited a significant increase in the surface area occupied by multi-nucleated osteoclasts (p<0.001). However, salubrinal treated unloaded mice significantly decreased it compared to unloaded mice without salubrinal treatment (p<0.001; Fig. 6B ). To further evaluate the effects of salubrinal on the formation of mature osteoclasts in vitro, three dosages of salubrinal (1, 2, and 5 µM) were applied to the bone marrow-derived cells isolated from HU. Compared to the HU control, in vitro administration of salubrinal for a 6-day culture period resulted in a significant decrease in osteoclast formation (all p<0.001; Fig. 6C ). To test the effects of salubrinal on the late development of osteoclasts, salubrinal was administered on days 4 to 6. This timeline was also able to provide a significant decrease in osteoclast formation in a time-and dosage-dependent manner (all p<0.001) in HU (Fig. 6C) .
Osteoclast function was evaluated through migration and adhesion assays.
Pre-osteoclast cells isolated from the unloaded mice were more active in migration than those from the age-matched control mice (p<0.001). In addition, pre-osteoclast cells isolated from the salubrinal treated mice presented a significantly reduced migration rate compared to unloaded mice (p<0.001; Fig. 6D) . A significant decrease in osteoclast migration was observed in a dosage-dependent manner in vitro (all p<0.001 for 1, 2 and 5 µM; Fig. 6E ). In M-CSF mediated adhesion, the cells isolated from the unloaded mice presented stronger adhesion than those from the age-matched control (p<0.001). Compared to the cells isolated from the unloaded mice, the cells from the salubrinal-treated mice exhibited a significant reduction in osteoclast adhesion (p<0.001; Fig. 6F ). In vitro analysis revealed a significant decrease in the osteoclasts adhesion in a dosage-dependent manner (all p<0.001 for 1, 2 and 5 µM; 
Salubrinal-driven suppression in CFU-M and CFU-GM of mature osteoclasts
The number of CFU-M and CFU-GM, representing the number of osteoclast progenitors from unloaded mice was significantly higher than that of AC (both p<0.001). Cells derived from mice treated with salubrinal had the significantly lower numbers of CFU-M and CFU-GM (both p<0.001; Fig. 7A&B ). After administration of salubrinal at 1, 2, and 5µM, a statistically significant dosage-dependent decrease in both CFU-M and CFU-GM was observed (both p<0.001; Fig. 7C&D ).
Salubrinal-driven alteration in NFATc1
Immunohistochemistry staining of NFATc1 showed the unloading-driven upregulation of osteoclasts. Specifically, NFATc1-positive cells in salubrinal-treated mice were significantly decreased (p<0.01; Fig. 7E ).
Salubrinal protects osteogenesis against ER stress in vitro and in vivo
Tunicamycin was used as an activator of ER stress. We employed salubrinal at 0.2 to 5 μM, and evaluated their effects in the presence of tunicamycin. Tunicamycin 18 increased viability of RAW264.7 cells at 100 ng/ml, but salubrinal partially inhibited it in a dose-dependent manner (both p<0.05 at sal 1μM and 5μM; Fig. 8A ).
Tunicamycin inhibited viability of MC3T3-E1 cells at 100 ng/ml, while salubrinal restored the viability in a dose-dependent manner (p<0.05 at sal 1μM; p<0.01 at sal 5μM; Fig. 8B ). TUNEL-positive MC3T3-E1 cells were significantly increased in the presence of tunicamycin, whereas salubrinal treatment significantly decreased TUNEL positive cells (both p<0.001; Fig. 8C ).
Western blot analysis demonstrated that salubrinal increased the level of Bip, p-eIF2α/eIF2α (both p<0.05) and ATF4 (p<0.01), but decreased the level of CHOP in vitro (p<0.01) (Fig. 8D) . Salubrinal increased the level of phosphorylated eIF2α (p<0.05; p-eIF2α), while it decreased the level of RANKL, cathepsin K and CHOP (all p<0.05) compared to the unloaded mice in vivo (Fig. 8E) .
Discussion
This study demonstrates that the ER stress plays a critical role in the pathogenesis of disuse osteoporosis. Using the tail suspended mice as a disuse osteoporosis model, unloading-driven reduction in femoral B.Ar/T.Ar was observed in a time-dependent fashion. The number of osteoblasts on the distal femora was significantly decreased in the unloaded mice. TRAP staining showed that Oc.S/BS f was increased in the unloaded mice. Unloading significantly increased the expression of Bip, p-eIF2α and ATF4 within 12 h of tail suspension, but decreased at later time points in HU2d to HU14d. The results indicate that short-term ER stress can protect cell through increasing Bip, p-eIF2α and ATF4 level, whereas long-term unloading induces apoptosis by inhibiting Bip, p-eIF2α and ATF4. The expression of CHOP showed a time-dependent increase (Fig. 8F) . Furthermore, to understand the role of ER stress in induction of disuse osteoporosis, the effect of salubrinal as an eIF2α dephosphorylation inhibitor that block unloading-induced ER stress was investigated.
Administration of salubrinal significantly suppressed unloading-induced bone loss and prevented apoptosis. Salubrinal also evaluated the levels of Bip, p-eIF2α/eIF2α, ATF4, RANKL, CHOP, and cathepsin K in tail-suspended mice. Meanwhile, administration of salubrinal in age-matched control (non-osteoporotic mice), no detectable changes were observed on bone formation and osteoclastogenesis (data not shown). These results showed that unloading-induced disuse osteoporosis modulates the expression of Bip, p-eIF2α, ATF4 and CHOP, indicating the possibility that the ER stress is involved in disuse osteoporosis.
Although lots of models such as ovariectomy-induced osteoporosis, glucocorticoid-induced osteoporosis, and disuse osteoporosis has been generated [13, 39, 40] , disuse osteoporosis is selected in current study since the stimulus intensity and procedure of hindlimb suspension can be easy operated and quantified analysis for the development of osteoporosis. The tail-suspended animal model has been widely accepted as an effective disuse osteoporosis model for simulating bone loss [15, 22, 41] . In the current tail suspension experiment, bone formation was mildly inhibited and bone resorption was markedly increased in unloaded mice, these 20 changes are in accord with previous study [14, [42] [43] [44] . Our correlation analysis and linear regression showed that the expression level of p-eIF2α was positively associated with the number of bone-forming osteoblasts, and negatively associated with that of bone-resorbing osteoclasts. Therefore, disuse osteoporosis model was used in the current study.
In the second set of experiments, salubrinal was applied as a dissecting tool to evaluate the role of ER stress in the development and treatment of osteoporosis. As shown in previous study, salubrinal inhibited eIF2α dephosphorylation through ER stress in glucocorticoid induced bone loss animal model [12] . In our study, ER stress induced by unloading and was significantly inhibited by salubrinal in disuse osteoporosis. Our results showed that daily subcutaneous administration of salubrinal significantly suppressed unloading-induced decrease of bone mass. During bone remodeling progresses, osteoblasts and fibroblasts are generated from bone marrow mesenchymal stem cells [34] . To evaluate the proliferation and differentiation of these Our study consistent with salubrinal-driven augmentation of bone formation in the unloaded mice by decreasing ER stress, inhibiting eIF2α dephosphorylation by salubrinal prevents osteoblast apoptosis, accelerate the healing of bone wounds [45] , enhance bone formation [12] , and increase the mineralization of MC3T3 cells [32, 46] .
The elevated level of p-eIF2α contributes to osteoblast differentiation in disuse 21 osteoporosis by the suppression of cellular stress, such as stress to the ER and radiation, through decreasing translational efficiency in general, except for a set of proteins such as ATF4 [47] . Cell viability and TUNEL assays were conducted to evaluate apoptotic cells. In histological TUNEL assay in vivo, apoptotic cells were located in bone marrow cavity. For in vitro assay, ER stress induced osteoblast apoptosis, and salubrinal rescued it. However, osteoclast apoptosis was not observed in RAW264.7 cells.
The development of osteoclasts was suppressed by both subcutaneous injection of salubrinal as well as in vitro incubation of bone marrow-derived cells with salubrinal [32, 48] . Although the effects of salubrinal in RAKNL-induced osteoporosis were reported [32] , its therapy on disuse model that is one of clinical related osteoporosis has not been validated. Importantly, salubrinal suppressed the maturation of osteoclasts in both early and late development phases, the migration and adhesion of pre-osteoclasts. Furthermore, macrophage (G) and mononuclear (M) were osteoclast progenitors [25] . Salubrinal affected the development of osteoclasts in osteoporosis by CFU-M/CFU-GM assays. NFATc1 is usually expressed in osteoclasts, and is linked to osteoclastogenesis. Our previous studies have demonstrated that salubrinal suppresses osteoclastogenesis by reducing NFATc1 [28, 46] . The result for NFATc1 in this study is consistent with those previous studies. The osteoclast formation is associated with osteoclast-specific genes including RANKL and NFATc1,as well as ER stress [49] . Because of the role of Bip and phosphorylated eIF2α in reducing translational efficiency, the suppression of NFATc1 by salubrinal is likely to be regulated at least in part at the level of translation [50] . Osteoclastogenesis by unloading were reduced by salubrinal through regulation of Bip, eIF2α and NFATc1 (Fig. 8G) .
PERK (double-stranded RNA-activated protein kinase-like ER kinase) is one of the three principal kinases in the unfolded protein response (UPR) in ER stress. When activated, PERK phosphorylates eIF2α and inhibits general translational activities. In this way, an increase in p-eIF2α reduces the flux of proteins entering into the ER [1] .
In our study, we demonstrated that p-eIF2α/eIF2α was elevated in response to 22 short-term ER stress. For long-term stress, CCAAT/enhancer CHOP was elevated.
CHOP regulates expression of pro-apoptotic factors and blocks BCL-2. Hence, CHOP has the propensity to drive apoptosis [51] and thus cells might be led to apoptosis. Our linear regression analysis showed that the expression level of p-eIF2α was positively associated with the number of bone-forming osteoblasts, and negatively associated with that of bone-resorbing osteoclasts.
In summary, this study demonstrates the crucial role of ER stress in the Further analysis will target the molecular mechanism of salubrinal's action warrants the potential development of a novel strategy for combating unloading-driven osteoporosis through eIF2α signaling. 
